SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-007237
Filing Date
2019-04-26
Accepted
2019-04-26 17:16:50
Documents
3
Period of Report
2019-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k042219_bioxytraninc.htm 8-K 25157
2 INVESTOR RELATIONS AGREEMENT BETWEEN BIOXYTRAN, INC. AND RESOURCES UNLIMITED NW f8k042219ex10-23_bioxytran.htm EX-10.23 34973
3 GRAPHIC img_001.jpg GRAPHIC 24511
  Complete submission text file 0001213900-19-007237.txt   95570
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 19772836
SIC: 2834 Pharmaceutical Preparations